Acceder

mugiwara

Se registró el 10/06/2013
--
Publicaciones
Recomendaciones
14
Seguidores
Posición en Rankia
999,999
Posición último año
mugiwara 16/01/20 10:23
Ha recomendado Re: Farmas USA de
mugiwara 15/01/20 11:56
Ha recomendado Re: Farmas USA de
mugiwara 15/01/20 10:22
Ha recomendado Re: Farmas USA de
mugiwara 15/01/20 10:19
Ha recomendado Re: Farmas USA de
mugiwara 15/01/20 08:31
Ha recomendado Re: Farmas USA de
mugiwara 15/01/20 08:30
Ha recomendado Re: Farmas USA de
mugiwara 15/01/20 08:17
Ha recomendado Re: Farmas USA de
mugiwara 15/01/20 08:17
Ha respondido al tema Farmas USA
CLVSPDUFA 15 de mayo.  Clovis Oncology’s Rubraca® (Rucaparib) Granted FDA Priority Review For Advanced Prostate Cancer Clovis seeks U.S. approval for rucaparib as monotherapy treatment for patients with BRCA1/2-mutant recurrent, metastatic castrate-resistant prostate cancer- FDA submission based on data from TRITON clinical program in advanced prostate cancer- FDA has assigned PDUFA date of May 15, 2020 https://ir.clovisoncology.com/investors-and-news/news-releases/press-release-details/2020/Clovis-Oncologys-Rubraca-rucaparib-Granted-FDA-Priority-Review-for-Advanced-Prostate-Cancer/default.aspx 
Ir a respuesta